USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication

Author:

Pan Ting1ORCID,Song Zheng1,Wu Liyang1,Liu Guangyan1ORCID,Ma Xiancai1ORCID,Peng Zhilin1,Zhou Mo1,Liang Liting1,Liu Bingfeng1,Liu Jun1,Zhang Junsong1,Zhang Xuanhong1,Huang Ryan1,Zhao Jiacong1,Li Yonghong2,Ling Xuemei2,Luo Yuewen1,Tang Xiaoping2,Cai Weiping2,Deng Kai1,Li Linghua2,Zhang Hui1ORCID

Affiliation:

1. Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

2. Infectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China

Abstract

The antiviral activity of host factor apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G, A3G) and its degradation mediated by human immunodeficiency virus type 1 (HIV-1) Vif protein are important topics. Although accumulating evidence indicates the importance of deubiquitination enzymes (DUBs) in innate immunity, it is unknown if they participate in A3G stability. Here, we found that USP49 directly interacts with A3G and efficiently removes ubiquitin, consequently increasing A3G protein expression and significantly enhancing its anti-HIV-1 activity. Unexpectedly, A3G degradation was also mediated by a Vif- and cullin-ring-independent pathway, which was effectively counteracted by USP49. Furthermore, clinical data suggested that USP49 is correlated with A3G protein expression and hypermutations in Vif-positive proviruses, and inversely with the intact provirus ratio in the HIV-1 latent reservoir. Our studies demonstrated a mechanism to effectively stabilize A3G expression, which could comprise a target to control HIV-1 infection and eradicate the latent reservoir.

Funder

National Special Research Program of China for Important Infectious Diseases

National Natural Science Foundation of China

The International Collaboration Program of the Natural Science Foundation of China and the US NIH

The Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou

The Science and Technology Planning Project of Guangzhou

Pearl River S and T Nova Program of Guangzhou

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3